President Bush has signed into law the largest Medicare overhaul in history - and it's time for skilled nursing facilities to prepare for the fallout. SNFs have won some tough battles: The Medicare Prescription Drug, Improvement and Modernization Act immediately renews a two-year moratorium on therapy caps and more than doubles the reimbursement rate for AIDS-related skilled care. But providers and their legal counsel still are wading through the hundreds of pages that spell out the Act's finer points. The consensus so far: Despite the magnitude of the historic legislation, it's not likely to rock nursing homes' world. "There's little else in the bill that directly benefits SNFs," summarizes Marie Infante, an attorney with Mintz, Levis, Cohn, Ferris, Glovsky & Popeo in Washington. But SNFs can't ignore the legislation altogether: "There are a few aspects of the legislation that affect nursing facilities in relatively minor ways," says Susan Kayser, an attorney with New York City's Duane Morris. The devil could be in the details, so providers should be diligent in sorting out the ways in which the Medicare Act could touch their businesses and affect their ability to provide care. Providers should pay close attention to the following provisions, experts agree:
Still, the average provider may find some shelter in the increased rate, particularly in light of recent charges of discrimination against prospective HIV-positive residents. The new rate will be effective for services rendered on or after October 1, 2004, with the provision sunsetting when the RUG system is revamped to include such costs, explains Dawn Segler of the Tallahassee, FL, office of Moore Stephens Lovelace, an accounting and management firm. It's not clear at this point how relationships will change, offers Barbara Gay, director of information for the American Association of Homes and Services for the Aging. For example, it's unclear at this point whether the nursing home pharmacy has to join the managed care plan, she points out. "The administrative appeals process could become much more adversarial in nature than it already is, particularly on the reimbursement side," predicts Infante. The act also clarifies that CMS may retroactively apply substantive changes in rules, manual sections and policies and other guidance publications, as long as the HHS secretary determines that doing so is in the public interest, according to a summary from the Washington law offices of McDermott Will & Emery. Key provisions under this heading include combining the functions of fiscal intermediaries for Part A and carriers for Part B and creating a new breed, Medicare Administrative Contractors (MACs), that will have combined authority, according to McDermott Will & Emery. In addition, the Act effectively tightens the reins on CMS, creating new performance standards for the agency. That means CMS can't drag its feet any longer when it comes to issuing regulations, at least not without a good excuse. The agency can't let three years elapse from proposed rule to final regulation unless it justifies publicly the reason for the delay. And new material can't be introduced in a final rule unless it is a "logical outgrowth" of what was originally proposed, the provision says. The full bill text is at http://thomas.loc.gov/cgi-bin/bdquery/?d108:h.r.00001:.